Human stem cells and articular cartilage regeneration

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedics

Background:

• Articular cartilage regeneration is a significant unmet medical need, particularly for post-traumatic osteoarthritis.
• Current strategies involve chondrocytes, stem cells, scaffolds, and growth factors, with stem cells being crucial due to cartilage's limited self-healing capacity.
• Adult stem cells from various sources (bone marrow, adipose, etc.) exhibit differing chondrogenic potentials, while pluripotent stem cells offer greater proliferative capacity.

Purpose of the Study:

• To review the current state of stem cell-based articular cartilage regeneration.
• To discuss the potential and challenges of using adult stem cells and pluripotent stem cells (embryonic stem cells and induced pluripotent stem cells) for cartilage repair.
• To highlight the role of transforming growth factor beta superfamily signals in chondrogenesis.

Main Methods:

• Review of existing literature on stem cell sources and chondrogenesis for articular cartilage regeneration.
• Analysis of the chondrogenic potential and limitations of adult stem cells, embryonic stem cells, and induced pluripotent stem cells.
• Examination of the role of signaling pathways, such as TGF-β, in cartilage formation.

Main Results:

• Adult stem cells vary in their ability to differentiate into chondrocytes.
• Embryonic stem cells (ES cells) show chondrogenic potential but raise ethical concerns for clinical use.
• Induced pluripotent stem cells (iPS cells) possess chondrogenic capacity, but their optimization, generation, and differentiation into articular chondrocytes require further intensive investigation.

Conclusions:

• Stem cell-based therapies are critical for articular cartilage regeneration.
• While iPS cells offer a promising alternative to ES cells, significant research is still needed to overcome challenges in their clinical application for articular cartilage repair.